Joel Baglole

Joel Baglole

Joel Baglole has been a financial reporter for more than 20 years. For five years, Mr. Baglole was a staff reporter at The Wall Street Journal, where he wrote articles from Iceland to Indonesia and covered topics ranging from the automotive and airline industries to investment banks and global stock markets.

Mr. Baglole has also worked for The Washington Post and Toronto Star newspapers, and has contributed to business focused websites such as The Motley Fool and Investopedia. At InvestorPlace, he covers a wide range of large and small cap stocks, as well as political and economic issues that impact financial markets.

Check out Joel’s TipRanks profile.

Recent Articles

DKNG Stock Alert: Why DraftKings Is Down 20% Today

Shares of DKNG stock are under pressure after the Boston-based sports betting company issued a disappointing 2023 outlook.

5 Best Stocks to Buy if You Have $250 to Spend

While U.S. markets posting their worst first half to any year since 1970 has been stressful, it has also presented an enormous opportunity for investors. With as little as $250, investors can now buy multiple shares of some of the best run and most dominant companies in the world.

Why Is Aurinia Pharmaceuticals (AUPH) Stock Down 30%?

Despite strong Q3 earnings, shares of AUPH stock are in steep decline today after it lowered its full-year sales guidance.

7 Stocks That Could Pop With The Holidays

Indications are that Americans plan to spend more money during the holidays compared to last year, and these companies should benefit.

$5 Billion Opioid Settlement Boosts CVS Stock. Here’s Why.

CVS stock is trending after the pharmacy retailer reported strong Q3 earnings and settled legal claims related to the opioid crisis.